Skip to main content
. 2018 Nov 13;17(1):1299–1305. doi: 10.3892/ol.2018.9694

Table II.

Clinicopathological characteristics of 877 patients with gastric cancer.

Characteristic No. (%)
Age, years
  ≤60 459 (52.3)
  >60 418 (47.7)
Sex
  Male 605 (69.0)
  Female 272 (31.0)
Tumor location
  Upper 179 (20.4)
  Middle 137 (15.6)
  Lower 550 (62.7)
  Entire 11 (1.3)
Tumor size, cm
  ≤5 568 (64.8)
  >5 309 (35.2)
Tumor differentiation
  Well 44 (5.0)
  Moderately 317 (36.1)
  Poorly 498 (56.8)
  Undifferentiated 18 (2.1)
pT stage
  T1 91 (10.4)
  T2 141 (16.1)
  T3 423 (48.2)
  T4a 211 (24.1)
  T4b 11 (1.3)
pN stage
  N0 223 (25.4)
  N1 175 (20.0)
  N2 265 (30.2)
  N3a 146 (16.6)
  N3b 68 (7.8)
TNM stage
  I 126 (14.4)
  II 327 (37.3)
  IIIA 183 (20.9)
  IIIB 175 (20.0)
  IIIC 66 (7.5)
MLR
  MLR0 223 (25.4)
  MLR1 203 (23.1)
  MLR2 451 (51.4)
LODDS
  LODDS1 261 (29.8)
  LODDS2 160 (18.2)
  LODDS3 312 (35.6)
  LODDS4 144 (16.4)
Number of LN retrieved
  <15 404 (46.1)
  ≥15 473 (53.9)
Postoperative chemotherapy
  Yes 275 (31.4)
  No 602 (68.6)

pT, tumor depth; pN, pathological node; TNM, tumor-node-metastasis; MLR, metastatic lymph node ratio; LODDS, log odds of positive nodes; LN, lymph nodes.